Guadecitabine sodium: Mechanism of Action

Guadecitabine sodium MOA:Targeting DNMT/DNA Methylation Pathway for Acute Myeloid Leukemia and Myelodysplastic Syndromes

🎯 check Guadecitabine sodium product page

Guadecitabine sodium is a potent DNA methyltransferase (DNMT) inhibitor. It affects IFN and cGAS-STING signaling pathways by inducing DNA hypomethylation, effectively promoting tumor immunogenicity, MHC antigen presentation, and inhibiting tumor proliferation.

Primary Applications and Mechanism of Action